Tag: MRNA-4157/V940

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to MRNA-4157/V940

U.K. trial for mRNA-based cancer therapy begins - LabPulse.com

Added to Collection on: 2024-02-07 23:27:25

Tags for this article:

Cancer immunotherapy
Biotechnology
Virotherapy
Pembrolizumab
Cancer vaccine
Immunotherapy
Checkpoint inhibitor
RNA therapeutics
MRNA-4157/V940
Moderna
United Kingdom

Click the tags to see associated articles and topics

View Article Details
Moderna (MRNA) Gears Up for Q4 Earnings: Will It Top Estimates? - Yahoo Finance

Added to Collection on: 2024-02-19 18:29:08

Tags for this article:

RNA vaccines
COVID-19 vaccination in the United States
Biotechnology
MRNA-4157/V940
Personalized medicine
Moderna
Pembrolizumab
Merck & Co.
Pfizer-BioNTech COVID-19 vaccine
Earnings surprise
COVID-19 vaccine
Moderna, Inc.
Free Stock Analysis ReportModerna Inc.

Click the tags to see associated articles and topics

View Article Details
mRNA vaccine technology changes cancer treatment landscape, offering promising ... - menafn

Added to Collection on: 2024-05-26 22:59:55

Tags for this article:

RNA
Biotechnology
Molecular biology
Molecular genetics
RNA therapeutics
BioNTech
Messenger RNA
Cancer treatment
Vaccine
MRNA-4157/V940
MRNA vaccine

Click the tags to see associated articles and topics

View Article Details
BioNTech cancer vaccine hits the spot in melanoma - Pharmaphorum

Added to Collection on: 2024-07-30 22:04:20

Tags for this article:

RNA vaccines
Cancer immunotherapy
Medical research
Clusters of differentiation
COVID-19 vaccination in the United States
Pembrolizumab
MRNA-4157/V940
PD-1 and PD-L1 inhibitors
Moderna
Programmed cell death protein 1
Pfizer-BioNTech COVID-19 vaccine
Cancer vaccine
Regeneron
BioNTech

Click the tags to see associated articles and topics

View Article Details
Flamingo's Phase II PEMDA-HN trial expands to UK and South Korea

Added to Collection on: 2024-08-09 17:08:21

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Pembrolizumab
Clinical endpoint
Favezelimab
Survival rate
MRNA-4157/V940

Click the tags to see associated articles and topics

View Article Details
PDS Biotech Announces Updated Results From VERSATILE-002 Phase 2 Clinical Trial ...

Added to Collection on: 2024-09-16 12:12:20

Tags for this article:

Cancer immunotherapy
Cervical cancer
Infectious causes of cancer
Papillomavirus
Otorhinolaryngology
Human papillomavirus infection
Pembrolizumab
Head and neck cancer
Merck & Co.
Checkpoint inhibitor
HPV-positive oropharyngeal cancer
MRNA-4157/V940
pds biotechnology corporation

Click the tags to see associated articles and topics

View Article Details
COVID-19 Vaccination Linked to Improved OS in Patients With Cancer Treated With ICIs

Added to Collection on: 2024-09-24 22:50:01

Tags for this article:

RNA vaccines
COVID-19 vaccination in the United States
RNA
MRNA vaccine
COVID-19 vaccine
Vaccine
MRNA-4157/V940
COVID-19 vaccine misinformation and hesitancy
Adam J. Grippin
the university of texas md anderson cancer center

Click the tags to see associated articles and topics

View Article Details
First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo - Cision News

Added to Collection on: 2024-11-06 21:52:14

Tags for this article:

Cancer
Immune system
Antineoplastic drugs
Orphan drugs
Melanoma
Pembrolizumab
Checkpoint inhibitor
Cancer treatment
Skin cancer
Programmed cell death protein 1
MRNA-4157/V940
Viralytics
Norway
Lytix Biopharma
OSLO
LTX-315

Click the tags to see associated articles and topics

View Article Details
Personalized Cancer Vaccine Market To Reach $1.45Bn By 2030

Added to Collection on: 2025-05-16 11:04:30

Tags for this article:

Cancer vaccines
Biotechnology
RNA vaccines
Medical research
RNA
Moderna
Cancer vaccine
BioNTech
CureVac
MRNA-4157/V940
MRNA vaccine
RNA therapeutics

Click the tags to see associated articles and topics

View Article Details
Moderna: to present progress in oncology at 2025 ESMO | MarketScreener

Added to Collection on: 2025-07-28 13:45:15

Tags for this article:

RNA
Cancer immunotherapy
Biotechnology
Pembrolizumab
Moderna
Oncology
Messenger RNA
Bladder cancer
MRNA-4157/V940

Click the tags to see associated articles and topics

View Article Details
Book a Demo